YES! YES! YES! A Vaccine Special
Newscast
00:00
Promising Vaccine Breakthrough by Pfizer and BioNTech
The chapter delves into the remarkable efficacy of a novel vaccine against coronavirus with a 90% effectiveness rate in early data analysis. It explains the importance of targeting the spike protein and discusses the distinction between epidemic and disease-modifying vaccines. Insights into the distribution challenges and the potential timeline for approval and immunization are also provided.
Transcript
Play full episode
